Cargando…
Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335373/ https://www.ncbi.nlm.nih.gov/pubmed/37441086 http://dx.doi.org/10.1093/noajnl/vdad075 |
_version_ | 1785070985392685056 |
---|---|
author | Wijnenga, Maarten M J Maas, Sybren L N van Dis, Vera Tesileanu, C Mircea S Kros, Johan M Dirven, Linda Hazelbag, Hans M Dubbink, Hendrikus J Vincent, Arnaud J P E French, Pim J van den Bent, Martin J |
author_facet | Wijnenga, Maarten M J Maas, Sybren L N van Dis, Vera Tesileanu, C Mircea S Kros, Johan M Dirven, Linda Hazelbag, Hans M Dubbink, Hendrikus J Vincent, Arnaud J P E French, Pim J van den Bent, Martin J |
author_sort | Wijnenga, Maarten M J |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10335373 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-103353732023-07-12 Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation Wijnenga, Maarten M J Maas, Sybren L N van Dis, Vera Tesileanu, C Mircea S Kros, Johan M Dirven, Linda Hazelbag, Hans M Dubbink, Hendrikus J Vincent, Arnaud J P E French, Pim J van den Bent, Martin J Neurooncol Adv Brief Communication Oxford University Press 2023-06-21 /pmc/articles/PMC10335373/ /pubmed/37441086 http://dx.doi.org/10.1093/noajnl/vdad075 Text en © The Author(s) 2023. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Communication Wijnenga, Maarten M J Maas, Sybren L N van Dis, Vera Tesileanu, C Mircea S Kros, Johan M Dirven, Linda Hazelbag, Hans M Dubbink, Hendrikus J Vincent, Arnaud J P E French, Pim J van den Bent, Martin J Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation |
title | Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation |
title_full | Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation |
title_fullStr | Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation |
title_full_unstemmed | Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation |
title_short | Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation |
title_sort | glioblastoma lacking necrosis or vascular proliferations: different clinical presentation but similar outcome, regardless of histology or isolated tert promoter mutation |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335373/ https://www.ncbi.nlm.nih.gov/pubmed/37441086 http://dx.doi.org/10.1093/noajnl/vdad075 |
work_keys_str_mv | AT wijnengamaartenmj glioblastomalackingnecrosisorvascularproliferationsdifferentclinicalpresentationbutsimilaroutcomeregardlessofhistologyorisolatedtertpromotermutation AT maassybrenln glioblastomalackingnecrosisorvascularproliferationsdifferentclinicalpresentationbutsimilaroutcomeregardlessofhistologyorisolatedtertpromotermutation AT vandisvera glioblastomalackingnecrosisorvascularproliferationsdifferentclinicalpresentationbutsimilaroutcomeregardlessofhistologyorisolatedtertpromotermutation AT tesileanucmirceas glioblastomalackingnecrosisorvascularproliferationsdifferentclinicalpresentationbutsimilaroutcomeregardlessofhistologyorisolatedtertpromotermutation AT krosjohanm glioblastomalackingnecrosisorvascularproliferationsdifferentclinicalpresentationbutsimilaroutcomeregardlessofhistologyorisolatedtertpromotermutation AT dirvenlinda glioblastomalackingnecrosisorvascularproliferationsdifferentclinicalpresentationbutsimilaroutcomeregardlessofhistologyorisolatedtertpromotermutation AT hazelbaghansm glioblastomalackingnecrosisorvascularproliferationsdifferentclinicalpresentationbutsimilaroutcomeregardlessofhistologyorisolatedtertpromotermutation AT dubbinkhendrikusj glioblastomalackingnecrosisorvascularproliferationsdifferentclinicalpresentationbutsimilaroutcomeregardlessofhistologyorisolatedtertpromotermutation AT vincentarnaudjpe glioblastomalackingnecrosisorvascularproliferationsdifferentclinicalpresentationbutsimilaroutcomeregardlessofhistologyorisolatedtertpromotermutation AT frenchpimj glioblastomalackingnecrosisorvascularproliferationsdifferentclinicalpresentationbutsimilaroutcomeregardlessofhistologyorisolatedtertpromotermutation AT vandenbentmartinj glioblastomalackingnecrosisorvascularproliferationsdifferentclinicalpresentationbutsimilaroutcomeregardlessofhistologyorisolatedtertpromotermutation |